Continuing Education for Pharmacy Professionals
At PTCE, our team includes pharmacists with expertise across various disease states and practice settings. They are committed to developing high-quality CE activities for pharmacy professionals to enhance their knowledge, competence, and skills so they can offer the highest level of pharmacy care to the patients they serve.
Already Registered? Log In Here
The Educated Pharmacist: Obesity Care Learning Center
This longitudinal learning initiative is designed to strengthen your competence in evidence-based ob...
Upcoming Live Credit
Directions in Oncology Pharmacy® 2026 Northeast
Saturday, November 7, 2026 | 8:00 AM–4:00 PM ET
Managed Care and the Growing Prevalence of Retinal Diseases: Discussions in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatments
Monday, November 9, 2026 | 6:00–7:30 PM ET
An Eye on Access: Managed Care Perspectives in Demodex Blepharitis
Tuesday, November 10, 2026 | 12:00 PM & 8:00 PM ET
Optimizing Access and Outcomes in Chronic Spontaneous Urticaria: Evaluating the Therapeutic Landscape Through a Managed Care Lens
November 11, 2026 | November 16, 2026 | November 30, 2026 | 1:00 PM & 8:00 PM ET
Browse All Free Pharmacy Activities
ASHP Midyear 2026
Tuesday, December 8, 2026, 11:30 AM–Wednesday, December 9, 2026, 1:00 PM ET
Bispecific Antibodies in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma: Clinical Evidence and Evolving Treatment Strategies
Thursday, December 3, 2026 | 1:00 PM and 8:00 PM ET
Breakthroughs Continue in the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis: Updating Managed Care Approaches
Wednesday, November 11, 2026 | 6:00–7:30 PM ET
APOL1-Mediated Kidney Disease: Preparing Pharmacists for a New Era of Targeted Therapy
Friday, December 18, 2026 | 1:00 PM & 8:00 PM ET
Precision Sequencing in Advanced GEA: Advanced Pharmacist Strategies for Targeting HER2 and CLDN18.2
Monday, December 14, 2026 | 1:00 PM & 8:00 PM ET
Transforming Generalized Myasthenia Gravis Care: The Evolving Role of Pharmacists in Optimizing Therapy and Long-Term Disease Management
1.0 Credit / Neurology
Reframing Cardiorenal-Metabolic Care: Advancing SGLT2 Inhibitors From Evidence to Implementation
Thursday, November 12, 2026 | 6:00–7:30 PM ET
Beyond Progression: Evidence Pathways for Oral SERDs in HR+/HER2– Metastatic Breast Cancer
November 13, 2026 | 1:00–2:00 PM ET | November 16, 2026 | 8:00–9:00 PM ET
Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care
1.0 Credit / Oncology, Patient Safety
Closing the Gap in Lipid Management: Guideline-Concordant Care and Nonstatin Advances Across the Health-System Continuum
Tuesday, November 17, 2026 | 7:00–8:30 PM ET
Considering First-Line Use of Nonsteroidal Topical Therapies to Improve Outcomes in Chronic, Inflammatory Skin Disease
1.0 Credit / Dermatology
Managed Care and the Growing Prevalence of Retinal Diseases: Discussions in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatments
Monday, November 9, 2026 | 6:00–7:30 PM ET
Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care
1.0 Credit / Nephrology
Talking Shots: A Pharmacist’s Guide to Evidence-Based Vaccine Conversations
November 18, 2026 | 1:00 PM & 8:00 PM ET
Advancing Evidence-Based Value in Transthyretin Amyloidosis Cardiomyopathy Care: Managed Care Strategies for Early Identification, Access, and Treatment
November 23, 2026 | 1:00 PM & 8:00 PM ET
PROC in Practice: Navigating Biomarkers, Pipeline, and Patient Safety in Platinum-Resistant Ovarian Cancer
December 10, 2026 | 1:00 PM & 8:00 PM ET
Optimizing Access and Outcomes in Chronic Spontaneous Urticaria: Evaluating the Therapeutic Landscape Through a Managed Care Lens
November 11, 2026 | November 16, 2026 | November 30, 2026 | 1:00 PM & 8:00 PM ET
Coverage, Access, and Managed Care Decision-Making: Evidence for Exon-Skipping Therapies in Duchenne Muscular Dystrophy
2.0 Credits / Neurology, Rare Diseases
Redefining Care in Polycythemia Vera and Essential Thrombocythemia: Emerging Evidence, Evolving Strategies, and the Pharmacist’s Role
1.5 Credit / Oncology
The Evolving IgA Nephropathy Landscape: Translating New Evidence and Updated Guidelines Into Managed Care Access Strategies
November 19, 2026 | December 1, 2026 | December 16, 2026 | 1:00 PM & 8:00 PM ET
The Educated Pharmacist—Weighing In: Continuing the Conversation—Breaking Barriers in Obesity Management: Localizing Care, Maximizing Treatment Access, and Sustaining Adherence
1.5 Credit / Endocrinology Diabetes and Metabolism
Weighing In: Optimizing GLP-1 RA and Dual GIP/GLP-1 RA Therapy Through Comprehensive Patient Care and Nutrition
Tuesday, December 15, 2026 | 1:00–2:30 PM ET
Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education
1.0 Credit / Immunization
Inside the Influenza Vaccine Vault: Navigating Guidelines, Administration, and Choice
1.5 Credit / Immunization
Why COVID-19 Still Matters: Ongoing Risk, Misperceptions, and Opportunities to Improve Vaccine Uptake
1.5 Credit / Immunization
Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care
1.0 Credit / Dermatology
Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care
1.0 Credit / Neurology
New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis
1.0 Credit / Immunology, Rheumatology, Nephrology
Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens
1.0 Credit / Ophthalmology/Optometry
Improving Outcomes in Fibrosing Interstitial Lung Diseases: Exploring New Mechanisms of Action and Indications to Inform Clinical and Managed Care Decision-Making
1.0 Credit / Pulmonology/Respiratory
Advancing the Management of Hidradenitis Suppurativa: Emerging Therapies and Managed Care Strategies Across Patient Populations
1.0 Credit / Hidradenitis Suppurativa
Continuing the Conversation: Optimizing Fibrosing ILD Outcomes: A Pharmacist-Led Approach to Evidence-Based Care
Thursday, December 3, 2026 | 1:00–2:00 PM ET
The Educated Pharmacist—Weighing In: Translating Evidence to Practice—A Multidisciplinary Analysis of Obesity Pharmacotherapy Implementation and Team-Based Care
1.5 Credit / General Pharmacy, Endocrinology, Diabetes, and Metabolism
Optimizing Nondrowsy Allergy Relief for Allergic Rhinitis: The Pharmacist’s Role in Evidence-Based OTC Decision-Making (Pharmacy Technician Credit)
2.0 Credit / Allergies
Directions in Oncology Pharmacy® 2026 Northeast
Saturday, November 7, 2026 | 8:00 AM–4:00 PM ET
Transforming IgA Nephropathy Management: Managed Care Applications of Evolving Evidence and Guidelines
1.5 Credits / Nephrology; Rare Diseases
Optimizing Nondrowsy Allergy Relief for Allergic Rhinitis: The Pharmacist’s Role in Evidence-Based OTC Decision-Making
2.0 Credits / Allergy
SERD Strategy Lab: A Blueprint for Pharmacist-Led Implementation of Oral SERDs in HR+/HER2– Metastatic Breast Cancer
Wednesday, December 2, 2026 | 1:00 PM & 8:00 PM ET
Translating KDIGO Updates and Clinical Evidence Into Managed Care Decision-Making in IgA Nephropathy
1.0 Credit / Endocrinology Diabetes and Metabolism
Cyclosporiasis on the Rise: What Pharmacists Need to Know
0.75 Credits / Infectious Disease
Optimizing Pediatric Medication Safety: Applying ADR Risk Factors and the KIDs List in Managed Care Practice
2.0 Credits / Pediatrics, Medication Safety
Advancing Intravenous Therapy Management: Pharmacist Strategies to Optimize Safety, Efficiency, and Workflow During Intravenous Fluid Shortages
2.0 Credits / Patient Safety
Navigating New and Emerging Therapeutic Targets to Optimize Treatment of Generalized Myasthenia Gravis: Understanding Disease Pathways and the Role of the Pharmacist
1.5 Credit / Neurology
Outsmart the Algorithm: Combating Misinformation at the Pharmacy Counter
1.0 Credit / General Pharmacy
Advancing Access to High-Quality, Biomarker-Guided Care for All Patients With mNSCLC
1 Credit / Oncology, Lung Cancer
Chronic Inflammatory Demyelinating Polyneuropathy in Practice: Navigating Treatment Selection and Ongoing Management
1.5 Credit / Neurology
ABC With ADCs: Advancing Breast Cancer With Antibody-Drug Conjugates
1.25 Credit / Oncology
PI3K/AKT Simulation Sprint: Optimizing Pathway-Targeted Therapy in HR+ Metastatic Breast Cancer
1.25 Credit / Oncology